Hamps Bio Limited has launched its IPO, which is open for subscription starting from December 13, 2024. The IPO is a fresh issue of 12,20,000 shares, amounting to a total issue size of ₹6.22 crores. The IPO will close on December 17, 2024. Allotment details are expected to be finalised by December 18, 2024, and the shares will be listed on BSE SME on December 20, 2024.
The price for the Hamps Bio IPO is ₹51 per share, and the minimum IPO lot size is 2,000 shares.
Apply for the Hamps Bio Limited IPO today in a few steps!
Hamps Bio Limited BSE SME IPO Timeline (Tentative)
Here’s a quick look at the Hamps Bio IPO details:
Key Detail | Information |
IPO Opening Date | December 13, 2024 |
IPO Closing Date | December 17, 2024 |
Allotment Date | December 18, 2024 |
Listing Date | December 20, 2024 |
Face Value | ₹10 per share |
Price | ₹51 per share |
Minimum Bid Quantity | 2000 |
Maximum Bid Quantity | 1158000 |
Registrar | BIGSHARE SERVICES PRIVATE LTD |
Minimum Lot Size | 2,000 shares |
Issue Type | Fixed Price Issue IPO |
Listing At | BSE SME |
Hamps Bio Limited: Company Overview
Hamps Bio Limited, established in 2007, is engaged in marketing and distributing pharmaceutical products. These include tablets, syrups, capsules, injectables, oils, and nutritional supplements. The company operates across India and exports its freeze-dried and frozen products to several countries, including the US, Canada, and the EU. Hamps Bio’s products are sold through over 50 distributors and popular e-commerce platforms like Amazon, Flipkart, and Jio Mart.
The company operates in two main business segments:
- Pharmaceuticals
- Freeze-Dried and Frozen Products
The company offers over 180 products.
Apply for Hamps Bio Limited IPO with a free demat account!
Here are the key details for Hamps Bio Limited IPO:
- Hamps Bio IPO Launch Date: December 13, 2024
- Hamps Bio IPO Closing Date: December 17, 2024
- Hamps Bio IPOAllotment Date: December 18, 2024
- Hamps Bio IPOPrice: ₹51 per share
- Hamps Bio IPO Lot Size: 2,000 shares
- Book Running Lead Manager: Marwadi Chandarana Intermediaries Brokers Pvt. Ltd.
- Registrar: Bigshare Services Pvt. Ltd.
- Hamps Bio IPO GMP: ₹21, as of Dec 12th 2024, 01:57 PM.
Performance Overview of Hamps Bio Limited
Hamps Bio Limited has shown significant growth over the past few years.
In FY 2023-24, the company reported a 16.41% increase in revenue. The profit after tax (PAT) also rose impressively by 39.47%.
Here is a brief table that shows Hamps Bio Ltd’s performance in the past few years:
Year | Assets (₹ Lakhs) | Revenue (₹ Lakhs) | Profit After Tax (₹ Lakhs) | Net Worth (₹ Lakhs) | Reserves and Surplus (₹ Lakhs) | Total Borrowing (₹ Lakhs) |
31 Oct 2024 | 644.00 | 436.42 | 34.08 | 370.78 | 57.18 | 138.31 |
31 Mar 2024 | 514.77 | 650.13 | 50.07 | 337.42 | 141.42 | 104.52 |
31 Mar 2023 | 395.87 | 558.49 | 35.90 | 136.30 | -13.70 | 173.77 |
31 Mar 2022 | 364.31 | 534.46 | 12.15 | 100.57 | -49.43 | 204.31 |
FAQs – Hamps Bio Limited IPO
Hamps Bio Limited is a pharmaceutical company that markets products like tablets, syrups, capsules, injectables, oils, and nutritional supplements. It also deals with freeze-dried and frozen products.
The Hamps Bio IPO opens on December 13, 2024, and closes on December 17, 2024.
The minimum lot size is 2,000 shares, which means you’ll need to apply for at least that many shares if you plan to invest.
The allotment of Hamps Bio IPO will be finalized on December 18, 2024.
The price of Hamps Bio IPO is ₹51 per share.
The IPO is expected to be listed on BSE SME on December 20, 2024.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.